<DOC>
	<DOC>NCT02182934</DOC>
	<brief_summary>To assess the efficacy of Ginsana in improving hemoglobin re-oxygenation in healthy, recreational sports people and to assess the safety of the product.</brief_summary>
	<brief_title>Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy Recreational Sports People</brief_title>
	<detailed_description />
	<criteria>Male and female volunteers between 18 and 40 years old Females must test negative for pregnancy Recreational athletes according to the american college of sports medicine (ACSM) definition Familiar with the cycle ergometer exercise methodology Written inform consent according to good clinical practice (GCP) and local regulations Pre treatment and/or concomitant treatment with any drug that any drug that may influence the trial symptomatology Alcohol and drug abuse as stated in the clinical trial manual Smokers Known hypertension Known hypercholesterolemia (moderate/severe) Female volunteers taking oral or injectable contraceptives Female volunteers of child bearing potential not using adequate means of birth control, other than contraceptive pills [intrauterine devices (IUDs)] Pregnancy and/or lactation Liver and/or renal and/or vascular disease Relevant allergy or known hypersensitivity to the investigational drug or its excipients Participation in another clinical trial within the last 4 weeks before the date of inclusion or concurrent participation in another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>